PSO Exciting: Clinical Pearls and Emerging Therapies For Psoriasis The field of dermatology continues to evolve at a rapid pace, bringing groundbreaking research from the lab to the clinic. As…
Read More
Trending Article Alert Integrated skincare—the future of aesthetic outcomes? A roundtable, featured at the Thriving in Diversity webinar series, brought together leading dermatologists and cosmetic surgeons to discuss how integrated…
Read More
Did You Miss It? How does the roflumilast cream vehicle compare? For patients with inflammatory dermatologic conditions, a hydrating vehicle is key to improving the skin barrier without irritation. But…
Read More
Listen in on a panel discussion on the use of colloidal oat in skin care. Drs Friedman, Chovatiya, and Heath will share their insights on the history and science behind…
Read More
From the Vault Isotretinoin remains the gold standard for treating severe nodulocystic acne, yet concerns about its potential psychiatric effects continue to spark debate. While high-quality studies have found no…
Read More
Featured Podcast Managing alopecia is already anxiety provoking enough, but throw some inflammatory scalp diseases into the mix...ok deep breaths...think of a happy place. So happy your brain brought you…
Read More
Managing alopecia is already anxiety provoking enough, but throw some inflammatory scalp diseases into the mix...ok deep breaths...think of a happy place. So happy your brain brought you to this…
Read More
Featured Article Acanthosis nigricans disproportionately affects individuals with darker skin tones, yet no FDA-approved treatment currently exists. As the demand for effective therapies grows, the dermatology community faces a critical challenge:…
Read More
Check out our all-new JDD Video Abstract from Zoe Diana Draelos, MD, who assesses the vehicle for roflumilast cream compared to a ceramide-containing moisturizing cream in treating mild eczema.
Read More
Featured Article Have you missed this November 2024 article that's been making headlines? GLP-1 receptor agonists (GLP1RAs), including liraglutide and semaglutide, are proving effective beyond their established roles in weight…
Read More
Featured Article Who is at risk for hypertrophic scars and keloids? A study of 6,249 patients reveals that hypertrophic scars and keloids are significantly more common in Black/African American individuals…
Read More
Featured Article TikTok and acne: misinformation or opportunity? With TikTok's massive reach, it's a growing hub for acne education, including treatments like spironolactone. However, most content consists of unreliable patient testimonials,…
Read More
